Study Links Cardiac Output to Brain Aging in APOE4 Carriers
Heart health and brain health are often seen as separate issues, but new research indicates a significant connection, particularly for individuals with a higher genetic risk for Alzheimer's disease due to the APOE4 gene variant. An 11-year longitudinal study published in Alzheimer's & Dementia is the first to examine how subtle cardiac dysfunction relates to brain atrophy over time. Researchers from the Vanderbilt Memory and Alzheimer's Center tracked 756 middle-aged and older adults, finding that lower cardiac output—meaning the heart pumps less blood per minute—was linked to accelerated brain shrinkage, but only in those carrying the APOE4 variant.
The study utilized echocardiograms to measure cardiac output at the beginning and MRI scans to monitor brain volume changes throughout the follow-up period. Participants, aged 50 to 92, had no prior history of stroke, dementia, or heart failure. The findings revealed that for APOE4 carriers, lower baseline cardiac output correlated with an increase in fluid-filled spaces in the brain over time, indicating that surrounding brain tissue, especially in memory centers, is diminishing. In contrast, no significant relationship was observed between cardiac output and brain volume changes in non-APOE4 carriers.
Notably, the APOE4 gene appears to heighten the brain's sensitivity to even minor reductions in blood flow. This gene variant affects specialized brain support cells and is associated with a compromised barrier that protects the brain from harmful substances. When blood flow decreases slightly, this barrier becomes less effective, leaving brain cells more vulnerable to damage, which may accelerate the loss of brain tissue that precedes cognitive decline.
The study's results were particularly pronounced in the brain's memory center, which is most closely associated with early changes seen in Alzheimer's disease. APOE4 carriers with lower cardiac output also exhibited smaller total brain volumes, as well as reduced volumes in the temporal lobe, involved in memory and language, and the occipital lobe, responsible for visual processing.
The researchers suggest that the memory center may be particularly susceptible to reduced blood flow due to its lower density of blood vessels compared to other regions, making it more sensitive to fluctuations in circulation. While a heart that pumps slightly less efficiently may not be concerning for the general population, for APOE4 carriers, this can increase the risk of brain degeneration over the years.
The authors of the study advocate for cardiac screening as a potential tool for identifying individuals at higher risk for brain degeneration, particularly in middle age before symptoms appear. This shift in perspective emphasizes the importance of maintaining optimal cardiac health to protect against cognitive decline in those with the APOE4 gene. If individuals are concerned about their heart health, discussing echocardiogram testing with their healthcare provider may be beneficial, especially for those who carry the APOE4 gene.




